OROPHARYNX CANCER
Clinical trials for OROPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX CANCER trials appear
Sign up with your email to follow new studies for OROPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood test could spare throat cancer patients harsh radiation
Disease control Recruiting nowThis study is testing a new approach for people with HPV-related throat cancer who have surgery. Researchers want to see if a simple blood test can identify patients who are unlikely to need follow-up radiation. If the blood test after surgery shows no signs of leftover cancer, p…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
Blood test could spare cancer patients harsh radiation
Disease control Recruiting nowThis study is testing if a blood test that looks for tiny bits of cancer DNA can help doctors decide which patients need radiation after surgery for HPV-related throat cancer. The goal is to see if some patients can safely delay radiation or receive a shorter course of treatment.…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
Doctors test shrinking radiation zone to spare throat cancer patients from harsh side effects
Disease control Recruiting nowThis study is testing a new, personalized way to plan radiation therapy for throat cancer. The goal is to shrink the area of healthy tissue that gets irradiated, aiming to reduce painful side effects like swallowing problems and taste loss, while still effectively treating the ca…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Doctors test cutting radiation for HPV throat cancer to spare patients harsh side effects
Disease control Recruiting nowThis study is testing whether doctors can safely lower the radiation dose for people with HPV-linked throat cancer. It uses a special scan partway through treatment to find patients who are responding very well. If the scan looks good, those patients will get less radiation, with…
Matched conditions: OROPHARYNX CANCER
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New program aims to speed up critical cancer treatment after surgery
Disease control Recruiting nowThis study is testing whether a patient navigation program called ENDURE helps people with head and neck cancer start their necessary radiation therapy sooner after surgery. It will compare the new program to the usual way patients are scheduled for treatment. The goal is to see …
Matched conditions: OROPHARYNX CANCER
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New Two-Drug attack on tough head & neck cancers
Disease control Recruiting nowThis study is testing whether a combination of two drugs, sacituzumab govitecan and cetuximab, can help control advanced head and neck cancer that has come back or spread after initial treatment. It will involve about 40 adults whose cancer has progressed despite standard therapy…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New combo aims to sharpen cancer fight, spare healthy tissue
Disease control Recruiting nowThis large study is testing two ideas to improve treatment for certain head and neck cancers. It will see if using a smaller, more precise radiation area and/or adding a drug called ATRA (a form of vitamin A) works better than standard radiation alone. The goal is to better contr…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test 'Living Drug' to fight HPV cancers
Disease control Recruiting nowThis study is testing a new personalized treatment for advanced cancers caused by HPV. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and infuse them back to try to shrink tumors before standard therapy like chemo or surgery. The goal…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Engineered immune cells target HPV cancers in new trial
Disease control Recruiting nowThis study is testing a new gene therapy for people with advanced cancers caused by HPV. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack HPV-infected cancer cells, and then infuse them back into the patient. The goal is to see if thi…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Could less radiation be enough for some throat cancers?
Disease control Recruiting nowThis study is testing a gentler radiation treatment for people with HPV-positive throat cancer who have already had surgery. Researchers want to see if using a lower radiation dose and targeting only the neck (instead of the original tumor site too) works as well as the standard,…
Matched conditions: OROPHARYNX CANCER
Phase: NA • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Groin tissue tested to rebuild cancer Patients' mouths, reduce scarring
Disease control Recruiting nowThis study is testing a new surgical method for rebuilding the mouth or throat after removing cancer. Surgeons will take a piece of skin and tissue from the groin area (external pudendal flap) to use in the reconstruction, hoping it causes fewer problems at the site where it's ta…
Matched conditions: OROPHARYNX CANCER
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Feb 27, 2026 15:17 UTC
-
Massive 20,000-Person study aims to catch throat cancer sooner
Knowledge-focused Recruiting nowThis study aims to find out how common oral HPV infection is in healthy adults over 40 in the Czech Republic. Researchers will enroll 20,000 participants to test a new screening method using gargle samples. The goal is to gather information that could lead to earlier detection of…
Matched conditions: OROPHARYNX CANCER
Phase: NA • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC